TNRR : Thai National Research ระบบคลังข้อมูลงานวิจัยไทย

จำนวนงานวิจัยจำแนกรายปี

บุคคลที่เคยร่วมงานวิจัย

ความเชี่ยวชาญ

บุคคลที่เคยร่วมงานวิจัย

#	นักวิจัย	ร่วมงาน
1	ธีระ ศิริสันธนะ	3
2	สุวัฒน์ จริยาเลิศศักดิ์	1

ปี

#	พ.ศ.	จำนวน
1	2545	1
2	2541	2
3	543	48

ผลงานวิจัย

#	หัวเรื่อง
ปี พ.ศ. 2545
1	A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand
ปี พ.ศ. 2541
2	Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients
3	A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus
ปี พ.ศ. ไม่ระบุ
4	Disseminated Penicillium marneffei infection in Southeast Asia
5	Disseminated Penicillium marneffei infection diagnosed on examination of a peripheral blood smear of a patient with human immunodeficiency virus infection
6	Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens
7	An efficacy study of itraconazole in the treatment of Penicillium marneffei infection
8	Penicillium marneffei infection in patients infected with human immunodeficiency virus
9	Maltreatment of Strongyloides Infection: Case Series and Worldwide Physicians-in-Training Survey
10	Discontinuation of secondary prophylaxis against penicilliosis marneffei in AIDS patients after HAART
11	Autochthonous visceral leishmaniasis: A report of a second case in Thailand
12	High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant
13	Clinical and epidemiological analyses of human pythiosis in Thailand
14	Streptococcus suis infection: a series of 41 cases from Chiang Mai University Hospital
15	Lymphadenopathy due to Penicillium marneffei infection: Diagnosis by fine needle aspiration cytology
16	A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus
17	Epidemiology and management of penicilliosis in human immunodeficiency virus-infected patients
18	Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients
19	Western immunoblot analysis of protein antigens of Penicillium marneffei
20	Impact of HIV-1 viral load on genotypic characteristics among patients failing non-nucleoside reverse trancriptase inhibitor-based first-line regimens in Northern Thailand
21	Streptococcus agalactiae in adults at chiang mai university hospital: A retrospective study
22	Comparison of in-house HIV-1 genotypic drug resistant test with commercial HIV-1 genotypic test kit
23	Two-year safety and tolerability study of enfuvertide use in salvage therapy of Thai HIV-1 experienced cases
24	Impact of the frequency of plasma HIV-1 RNA monitoring on the outcome of antiretroviral therapy
25	Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis
26	Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: A prospective multicenter study
27	Long-term CD4 cell count recovery among Thai naive HIV-infected patients initiating HAART at low CD4 cell count
28	Risk factors for extended-spectrum ?-lactamase-producing Klebsiella pneumoniae and Escherichia coli acquisition in a tertiary care teaching hospital in Thailand
29	Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: The recommendations of the thai AIDS society (TAS) 2008
30	Response
31	Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors
32	Sensitivity and specificity of using CD4+ measurement and clinical evaluation to determine antiretroviral treatment failure in Thailand
33	Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients
34	Undertreatment of Pain in HIV+ Adults in Thailand
35	Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: Aids clinical trials group study A5199, the international neurological study
36	Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings
37	Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings
38	Treatment outcomes of patients co-infected with tuberculosis and HIV at Chiang Mai university hospital, Thailand
39	Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: Pooled results from the phase 3 double-blind randomized ECHO and THRIVE trials
40	Epidemiology of adult candidemia at Chiang Mai University Hospital
41	Incidence and risk factors of antiretroviral treatment failure in treatment-na?ve HIV-infected patients at Chiang Mai University Hospital, Thailand
42	Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients
43	Current molecular epidemiology and recombination of HIV type 1 subtypes in Northern Thailand
44	Itraconazole vs fluconazole as a primary prophylaxis for fungal infections in HIV-infected patients in Thailand
45	A multinational study of neurological performance in antiretroviral therapy-na?ve HIV-1-infected persons in diverse resource-constrained settings
46	Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): A phase 3 randomised double-blind active-controlled trial
47	Penicillium marneffei infection in immunocompromised host
48	Resistance-associated mutations after initial antiretroviral treatment failure in a large cohort of patients infected with HIV-1 Subtype CRF01_AE
49	Correlation of CYP2B6-516G>T polymorphism with plasma efavirenz concentration and depression in HIV-infected adults in Northern Thailand
50	Discontinuation of primary and secondary prophylaxis for opportunistic infections in HIV-Infected Patients Who Had CD4+ Cell Count <200 cells/mm3 but Undetectable Plasma HIV-1 RNA: An Open-Label Randomized Controlled Trial
51	Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-na?ve patients in the ARTEMIS trial